TickerFactsScreenerDevelopers

AYTU BIOPHARMA, INC (AYTU) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $2.91M2014: $2.64M2015: $7.35M2016: $8.05M2017: $802.3K2018: $7.01M2019: $11.04M2020: $48.08M2021: $49.65M2022: $19.36M2023: $22.98M2024: $20.01M2025: $30.95M$30.95M
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$30.95M+54.7%
2024$20.01M-13.0%
2023$22.98M+18.7%
2022$19.36M-61.0%
2021$49.65M+3.3%
2020$48.08M+335.4%
2019$11.04M+57.5%
2018$7.01M+774.0%
2017$802.3K-90.0%
2016$8.05M+9.5%
2015$7.35M+178.6%
2014$2.64M-9.4%
2013$2.91M—